Demonstration and characterization of zeta (ζ), a growth-related opioid receptor, in a neuroblastoma cell line

Ian Zagon, Steven R. Goodman, Patricia McLaughlin

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Endogenous opioids and opioid receptors (i.e. endogenous opioid systems) are involved in carcinogenesis. Using homogenates of S20Y neuroblastoma (NB) cells grown in culture, the binding of a growth-selective ligand, [Me5]enkephalin, was examined to ascertain the zeta (ζ) opioid receptor. Specific and saturable binding of [3H]-[Met5]enkephalin was detected in NB cells; the data were consistent with a single binding site. Scatchard analysis yielded a Kd of 1.6 nM and a binding capacity Bmax off 48.1 fmol/mg protein; 14,000 receptors per cell were estimated. Binding was dependent on protein concentration, time, temperature, and pH, and was sensitive to 100 nM, but not 5 nM, Na+, Ca2+, and Mg2+; GppNHp at concentrations of 100-500 mM had little effect on binding. Optimal binding required protease inhibitors, and pretreatment of the tumor cell homogenates with trypsin markedly reduced [3H]-[Met5]enkphalin winding, suggesting that the binding site was proteinaceous in character. Displacement experiments indicated that [Met5]enkephalin was the most potent displacer of [3H]-[Met5]enkephalin. Cell density (log, confluence, postconfluence) did not alter the Kd or Bmax. This study serves as the first demonstration and characterization of the zeta (ζ) opioid receptor in tissue culture cells. The homogenous nature of NB cell cultures, along with the enrichment in receptor number, provides an excellent model system to isolate and purify the ζ receptor.

Original languageEnglish (US)
Pages (from-to)181-186
Number of pages6
JournalBrain research
Volume511
Issue number2
DOIs
StatePublished - Mar 19 1990

Fingerprint

Enkephalins
Opioid Receptors
Neuroblastoma
Cell Line
Growth
Opioid Analgesics
Cell Culture Techniques
Binding Sites
Protease Inhibitors
Trypsin
Carcinogenesis
Proteins
Cell Count
Ligands
Temperature
Neoplasms
zeta receptor

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

@article{3dc84ff9f24945aaa391ba5caabe0392,
title = "Demonstration and characterization of zeta (ζ), a growth-related opioid receptor, in a neuroblastoma cell line",
abstract = "Endogenous opioids and opioid receptors (i.e. endogenous opioid systems) are involved in carcinogenesis. Using homogenates of S20Y neuroblastoma (NB) cells grown in culture, the binding of a growth-selective ligand, [Me5]enkephalin, was examined to ascertain the zeta (ζ) opioid receptor. Specific and saturable binding of [3H]-[Met5]enkephalin was detected in NB cells; the data were consistent with a single binding site. Scatchard analysis yielded a Kd of 1.6 nM and a binding capacity Bmax off 48.1 fmol/mg protein; 14,000 receptors per cell were estimated. Binding was dependent on protein concentration, time, temperature, and pH, and was sensitive to 100 nM, but not 5 nM, Na+, Ca2+, and Mg2+; GppNHp at concentrations of 100-500 mM had little effect on binding. Optimal binding required protease inhibitors, and pretreatment of the tumor cell homogenates with trypsin markedly reduced [3H]-[Met5]enkphalin winding, suggesting that the binding site was proteinaceous in character. Displacement experiments indicated that [Met5]enkephalin was the most potent displacer of [3H]-[Met5]enkephalin. Cell density (log, confluence, postconfluence) did not alter the Kd or Bmax. This study serves as the first demonstration and characterization of the zeta (ζ) opioid receptor in tissue culture cells. The homogenous nature of NB cell cultures, along with the enrichment in receptor number, provides an excellent model system to isolate and purify the ζ receptor.",
author = "Ian Zagon and Goodman, {Steven R.} and Patricia McLaughlin",
year = "1990",
month = "3",
day = "19",
doi = "10.1016/0006-8993(90)90159-9",
language = "English (US)",
volume = "511",
pages = "181--186",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

Demonstration and characterization of zeta (ζ), a growth-related opioid receptor, in a neuroblastoma cell line. / Zagon, Ian; Goodman, Steven R.; McLaughlin, Patricia.

In: Brain research, Vol. 511, No. 2, 19.03.1990, p. 181-186.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Demonstration and characterization of zeta (ζ), a growth-related opioid receptor, in a neuroblastoma cell line

AU - Zagon, Ian

AU - Goodman, Steven R.

AU - McLaughlin, Patricia

PY - 1990/3/19

Y1 - 1990/3/19

N2 - Endogenous opioids and opioid receptors (i.e. endogenous opioid systems) are involved in carcinogenesis. Using homogenates of S20Y neuroblastoma (NB) cells grown in culture, the binding of a growth-selective ligand, [Me5]enkephalin, was examined to ascertain the zeta (ζ) opioid receptor. Specific and saturable binding of [3H]-[Met5]enkephalin was detected in NB cells; the data were consistent with a single binding site. Scatchard analysis yielded a Kd of 1.6 nM and a binding capacity Bmax off 48.1 fmol/mg protein; 14,000 receptors per cell were estimated. Binding was dependent on protein concentration, time, temperature, and pH, and was sensitive to 100 nM, but not 5 nM, Na+, Ca2+, and Mg2+; GppNHp at concentrations of 100-500 mM had little effect on binding. Optimal binding required protease inhibitors, and pretreatment of the tumor cell homogenates with trypsin markedly reduced [3H]-[Met5]enkphalin winding, suggesting that the binding site was proteinaceous in character. Displacement experiments indicated that [Met5]enkephalin was the most potent displacer of [3H]-[Met5]enkephalin. Cell density (log, confluence, postconfluence) did not alter the Kd or Bmax. This study serves as the first demonstration and characterization of the zeta (ζ) opioid receptor in tissue culture cells. The homogenous nature of NB cell cultures, along with the enrichment in receptor number, provides an excellent model system to isolate and purify the ζ receptor.

AB - Endogenous opioids and opioid receptors (i.e. endogenous opioid systems) are involved in carcinogenesis. Using homogenates of S20Y neuroblastoma (NB) cells grown in culture, the binding of a growth-selective ligand, [Me5]enkephalin, was examined to ascertain the zeta (ζ) opioid receptor. Specific and saturable binding of [3H]-[Met5]enkephalin was detected in NB cells; the data were consistent with a single binding site. Scatchard analysis yielded a Kd of 1.6 nM and a binding capacity Bmax off 48.1 fmol/mg protein; 14,000 receptors per cell were estimated. Binding was dependent on protein concentration, time, temperature, and pH, and was sensitive to 100 nM, but not 5 nM, Na+, Ca2+, and Mg2+; GppNHp at concentrations of 100-500 mM had little effect on binding. Optimal binding required protease inhibitors, and pretreatment of the tumor cell homogenates with trypsin markedly reduced [3H]-[Met5]enkphalin winding, suggesting that the binding site was proteinaceous in character. Displacement experiments indicated that [Met5]enkephalin was the most potent displacer of [3H]-[Met5]enkephalin. Cell density (log, confluence, postconfluence) did not alter the Kd or Bmax. This study serves as the first demonstration and characterization of the zeta (ζ) opioid receptor in tissue culture cells. The homogenous nature of NB cell cultures, along with the enrichment in receptor number, provides an excellent model system to isolate and purify the ζ receptor.

UR - http://www.scopus.com/inward/record.url?scp=0025357232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025357232&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(90)90159-9

DO - 10.1016/0006-8993(90)90159-9

M3 - Article

C2 - 2159355

AN - SCOPUS:0025357232

VL - 511

SP - 181

EP - 186

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -